Heidelberg Pharma AG

XTRA:HPHA 株式レポート

時価総額：€101.1m

Heidelberg Pharma マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Andreas Pahl

最高経営責任者

€450.7k

報酬総額

CEO給与比率53.3%
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間1.7yrs
取締役会の平均在任期間12.5yrs

経営陣の近況

Recent updates

Is Heidelberg Pharma (ETR:HPHA) A Risky Investment?

Feb 16
Is Heidelberg Pharma (ETR:HPHA) A Risky Investment?

Heidelberg Pharma AG's (ETR:HPHA) Price In Tune With Revenues

Dec 05
Heidelberg Pharma AG's (ETR:HPHA) Price In Tune With Revenues

Industry Analysts Just Upgraded Their Heidelberg Pharma AG (ETR:HPHA) Revenue Forecasts By 21%

Jul 21
Industry Analysts Just Upgraded Their Heidelberg Pharma AG (ETR:HPHA) Revenue Forecasts By 21%

Analyst Forecasts For Heidelberg Pharma AG (ETR:HPHA) Are Surging Higher

Oct 16
Analyst Forecasts For Heidelberg Pharma AG (ETR:HPHA) Are Surging Higher

Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely

Nov 28
Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely

Heidelberg Pharma AG (ETR:HPHA) Analysts Are More Bearish Than They Used To Be

Mar 27
Heidelberg Pharma AG (ETR:HPHA) Analysts Are More Bearish Than They Used To Be

We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Mar 15
We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Investors Who Bought Heidelberg Pharma (ETR:HPHA) Shares Five Years Ago Are Now Up 245%

Jan 17
Investors Who Bought Heidelberg Pharma (ETR:HPHA) Shares Five Years Ago Are Now Up 245%

We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

Dec 14
We Think Heidelberg Pharma (ETR:HPHA) Needs To Drive Business Growth Carefully

CEO報酬分析

Heidelberg Pharma の収益と比較して、Andreas Pahl の報酬はどのように変化したか？
日付総報酬給与会社業績
Aug 31 2024n/an/a

-€19m

May 31 2024n/an/a

-€13m

Feb 29 2024n/an/a

-€18m

Nov 30 2023€451k€240k

-€20m

Aug 31 2023n/an/a

-€22m

May 31 2023n/an/a

-€27m

Feb 28 2023n/an/a

-€19m

Nov 30 2022€328k€240k

-€20m

Aug 31 2022n/an/a

-€21m

May 31 2022n/an/a

-€22m

Feb 28 2022n/an/a

-€27m

Nov 30 2021€442k€240k

-€26m

Aug 31 2021n/an/a

-€25m

May 31 2021n/an/a

-€22m

Feb 28 2021n/an/a

-€20m

Nov 30 2020€295k€207k

-€18m

Aug 31 2020n/an/a

-€17m

May 31 2020n/an/a

-€15m

Feb 29 2020n/an/a

-€12m

Nov 30 2019€288k€200k

-€10m

Aug 31 2019n/an/a

-€10m

May 31 2019n/an/a

-€11m

Feb 28 2019n/an/a

-€12m

Nov 30 2018€286k€200k

-€12m

Aug 31 2018n/an/a

-€11m

May 31 2018n/an/a

-€11m

Feb 28 2018n/an/a

-€11m

Nov 30 2017€241k€171k

-€11m

報酬と市場: Andreasの 総報酬 ($USD 472.39K ) は、 German市場 ($USD 474.67K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Andreasの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Andreas Pahl

less than a year

在職期間

€450,663

報酬

Prof. Dr. Andreas Pahl is Chief Executive Officer & Spokesman of the Executive Board at Heidelberg Pharma AG since February 1, 2024 and had been its Chief Scientific Officer and Member of the Executive Man...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Andreas Pahl
CEO & Spokesman of the Executive Boardless than a year€450.66kデータなし
Walter Miller
Chief Financial Officer1.5yrs€398.63kデータなし
Jorg Kemkowski
Chief Operating Officer1.8yrsデータなしデータなし
Sylvia Wimmer
Director Corporate Communicationno dataデータなしデータなし
Andras Strassz
Chief Medical Officer3.7yrsデータなしデータなし
George Badescu
Chief Business Officerno dataデータなしデータなし

1.7yrs

平均在職期間

経験豊富な経営陣: HPHAの経営陣は 経験豊富 とはみなされません ( 1.7年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Friedrich von Bohlen und Halbach
Member of the Supervisory Board19.6yrs€18.00kデータなし
Georg Baur
Deputy Chairman of the Supervisory Board24.8yrs€38.00kデータなし
Christof Hettich
Chairman of Supervisory Board14.5yrs€49.50kデータなし
Birgit Kudlek
Member of the Supervisory Board12.5yrs€21.75kデータなし
Mathias Hothum
Deputy Chairman of Supervisory Board9.3yrs€39.00kデータなし
Dongzhou Liu
Member of Supervisory Board2.4yrs€21.00kデータなし
Yan Xia
Member of Supervisory Board1.5yrs€9.96kデータなし

12.5yrs

平均在職期間

59.5yo

平均年齢

経験豊富なボード: HPHAの 取締役会 は経験豊富で 経験豊富 です ( 12.5年の平均在任期間)。